Clinical Trials List
Protocol Number101-5005A
2013-08-01 - 2016-07-31
Phase III
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
110 participants
-
Global
0 participants
